Bill > HB920

This bill requires drug manufacturers to limit the pricing of Glucagon-Like Peptide-1 (GLP-1) medications for health insurance plans in Louisiana. GLP-1 medications are a type of drug that helps control blood sugar, digestion, and appetite, and can be taken as injections or orally. The bill establishes that health coverage plans cannot require an insured person to pay more than $200 for a 30-day supply of a GLP-1 medication, regardless of the specific dosage or type of medication prescribed. Additionally, the bill mandates that the Louisiana Medicaid program will cover GLP-1 medications for eligible individuals when prescribed by a provider, irrespective of their specific medical condition or diagnosis, and allows the Louisiana Department of Health to pursue federal approvals if necessary to implement this coverage.